Philippines suspends use of AstraZeneca vaccine for people under 60

Published: Updated:
Read Mode
100% Font Size
1 min read

Philippine health authorities suspended on Thursday the use of Astrazeneca’s COVID-19 vaccine for people below 60 years of age to investigate reports of blood clots coming from overseas.

For more coronavirus news, visit our dedicated page.

The temporary suspension came after the European Medicines Agency recommended to include blood clots as a rare side effect of the vaccine, Food and Drug Administration chief Rolando Enrique Domingo said in a statement, adding that there were no reports of such adverse side effects in the country.

The Philippines has so far received 525,600 doses of AstraZeneca’s vaccines, about a fifth of the country’s total inventory, through the COVAX facility.

Read more:

Australia to continue AstraZeneca vaccine rollout plan despite EU warning

Indonesia says arrival of 30 mln AstraZeneca vaccine doses delayed to 2022

Britons should be confident in UK vaccine monitoring system: Health Secretary

Top Content Trending